SEC Filings

SEC Filings

Filing date	Form	Description	View
Mar 01, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001603756-23-000009.pdf 0001603756-23-000009.rtf 0001603756-23-000009.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 01, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001603756-23-000010.pdf 0001603756-23-000010.rtf 0001603756-23-000010.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 23, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001562180-23-001810.pdf 0001562180-23-001810.rtf 0001562180-23-001810.xls
Feb 15, 2023	5	Annual filing director officer or owner of more than ten percent.	View HTML 0001562180-23-001435.pdf 0001562180-23-001435.rtf 0001562180-23-001435.xls
Feb 09, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-23-001379.pdf 0000315066-23-001379.rtf
Feb 09, 2023	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001104659-23-015407.pdf 0001104659-23-015407.rtf
Feb 02, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001562180-23-000871.pdf 0001562180-23-000871.rtf 0001562180-23-000871.xls
Feb 02, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001562180-23-000875.pdf 0001562180-23-000875.rtf 0001562180-23-000875.xls
Feb 02, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001562180-23-000876.pdf 0001562180-23-000876.rtf 0001562180-23-000876.xls
Feb 02, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001562180-23-000874.pdf 0001562180-23-000874.rtf 0001562180-23-000874.xls

Data provided by Kaleidoscope.

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US